FINANCIAL STATEMENTS Notes to the Consolidated Financial Statements Continued 14.
Property, plant and equipment Machinery Projects Other intangible assets Land and and Fixtures and under Amortisation of all intangible assets with finite useful lives is charged on a straight-line basis.
buildings Vehicles equipment equipment construction Total Cost $m $m $m $m $m $m Customer relationships: Customer relationships represent the value attributed to the existing direct customers that the Company acquired Balance at 1 January 2014 263 16 328 58 58 723 on the acquisition of subsidiaries.
The customer relationships have an average estimated useful life of 15 years 2014: 15 years.
Additions 17 2 14 5 51 89 Product related intangibles: Product related intangibles include four types: Acquisition of business 20 26 7 53 Disposals 2 6 1 9 a.
Product files and under-licenced products: $6 million 2014: $20 million of the product files and under-licence products intangibles Transfers 14 19 2 35 are assessed as having indefinite useful lives due to the expected longevity of the products.
Translation adjustment 12 1 17 2 3 35 b. Under-licence agreements: The estimated useful life of under-licence agreements varies from five to eleven years 2014: five to eleven years.
Balance at 1 January 2015 302 15 364 69 71 821 c. Product dossiers: Product dossiers have an average estimated useful life of 15 years 2014: 15 years.
Additions 8 1 6 4 66 85 Remeasurement note 43 1 1 d. In process product files: Mainly represent files acquired from Bedford that are in the process of being transferred to our Disposals 11 2 17 6 1 37 manufacturing facilities.
Transfers 12 24 8 44 Trade name: Trade names were mainly recognised on the acquisition of Hikma Germany GmbH Germany, Arab Pharmaceutical Translation adjustment 13 1 17 3 2 36 Manufacturing Company, Promopharm, and Ibn Al Baytar.
Balance at 31 December 2015 298 13 360 71 90 832 Accumulated depreciation The trade name recognised on the acquisition of Hikma Germany GmbH Germany is expected to have an indefinite economic useful life due to its expected longevity.
The carrying value of Hikma Germany GmbH Germany trade name is $5 million 2014: $5 million.
The trade Balance at 1 January 2014 58 10 170 40 2 280 names recognised on the acquisition of the other subsidiaries have useful lives that vary from three to twenty years.
Charge for the year 10 2 29 7 48 Impairment 1 1 Marketing rights and others Disposals 2 4 1 7 a.
Marketing rights: Marketing rights are amortised over their useful lives commencing in the year in which the rights are ready for use.
Translation adjustment 4 9 2 15 The estimated useful life of marketing rights varies from five to ten years.
b. In-process R&D: In-process R&D represents mainly the pipeline of products under development that were recognised on the acquisition Balance at 1 January 2015 64 10 186 44 3 307 of Arab Pharmaceutical Manufacturing Company and Hikma Pharma SAEEgypt.
The in-process R&D has an average estimated useful Charge for the year 11 1 30 8 50 life of 15 years 2014: 15 years.
Impairment 1 1 Disposals 2 9 5 16 c. Other acquisition related: This mainly represents intangible assets recognised on the acquisition of Thymoorgan, which relate to its Translation adjustment 5 1 9 2 17 specialist manufacturing capabilities.
The estimated useful life varies from 10 years to an indefinite useful life.
The carrying value of assets Balance at 31 December 2015 70 8 198 45 4 325 with indefinite lives is $1 million 2014: $1 million.
Carrying amount Software: Software intangibles mainly represent the Enterprise Resource Planning solutions that are being implemented in different At 31 December 2015 228 5 162 26 86 507 operations across the Group.
The software has an average estimated useful life of five years.
Carrying amount As at 31 December 2015, the Group had entered into contractual commitments for the acquisition of intangible assets of $49 million At 31 December 2014 238 5 178 25 68 514 2014: $45 million.
The net book value of the Groups property, plant and equipment includes an amount of $8 million 2014: $7 million in respect of assets held under finance lease.
As at 31 December 2015, the Group had pledged property, plant and equipment having a carrying value of $45 million 2014: $47 million as collateral for various long-term loans.
This amount includes both specific items around the Group and the net property, plant and equipment of the Groups businesses in Portugal, Germany, and Tunisia 2014: Portugal, Germany and Tunisia.
As at 31 December 2015, the Group entered into contractual commitments for the acquisition of property, plant and equipment amounting to $9 million 2014: $23 million.
